Edwards Lifesciences Corporation Research and Development Expense
Edwards Lifesciences Corporation (EW) reported Research and Development Expense of $278.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- Edwards Lifesciences Corporation research and development expense for the quarter ending 2026-06-30 was $278.90M, a 0.98% increase year-over-year.
- Edwards Lifesciences Corporation research and development expense for the quarter ending 2026-03-31 was $263.30M, a 3.42% increase year-over-year.
- Edwards Lifesciences Corporation research and development expense for the quarter ending 2025-12-31 was $267.70M, a 1.25% decline year-over-year.
- Edwards Lifesciences Corporation research and development expense for the quarter ending 2025-09-30 was $280.70M, a 10.77% increase year-over-year.
- Edwards Lifesciences Corporation research and development expense for fiscal 2025 was $1.08B, a 2.49% increase from fiscal 2024.
- Edwards Lifesciences Corporation research and development expense for fiscal 2024 was $1.05B, a 9.36% increase from fiscal 2023.
- Edwards Lifesciences Corporation research and development expense for fiscal 2023 was $962.90M, a 14.14% increase from fiscal 2022.
- Edwards Lifesciences Corporation research and development expense for fiscal 2022 was $843.60M, a 6.59% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $278.90M 10-Q · filed 2026-08-04 | $542.20M 10-Q · filed 2026-08-04 | $809.90M derived: sum of 3 quarters · filed 2026-08-04 | $1.09B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $263.30M 10-Q · filed 2026-05-06 | $531.00M derived: sum of 2 quarters · filed 2026-05-06 | $811.70M derived: sum of 3 quarters · filed 2026-05-06 | $1.09B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $267.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $548.40M derived: sum of 2 quarters · filed 2026-02-25 | $824.60M derived: sum of 3 quarters · filed 2026-08-04 | $1.08B 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $280.70M 10-Q · filed 2025-11-05 | $556.90M derived: sum of 2 quarters · filed 2026-08-04 | $811.50M 10-Q · filed 2025-11-05 | $1.08B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $276.20M 10-Q · filed 2026-08-04 | $530.80M 10-Q · filed 2026-08-04 | $801.90M derived: sum of 3 quarters · filed 2026-08-04 | $1.06B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $254.60M 10-Q · filed 2026-05-06 | $525.70M derived: sum of 2 quarters · filed 2026-05-06 | $779.10M derived: sum of 3 quarters · filed 2026-05-06 | $1.05B derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $271.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $524.50M derived: sum of 2 quarters · filed 2026-02-25 | $796.30M derived: sum of 3 quarters · filed 2026-02-25 | $1.05B 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $253.40M 10-Q · filed 2025-11-05 | $525.20M derived: sum of 2 quarters · filed 2025-11-05 | $781.90M 10-Q · filed 2025-11-05 | $1.02B derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $271.80M 10-Q · filed 2025-08-06 | $272.60M 10-Q · filed 2024-07-31 | $528.50M 10-Q · filed 2025-08-06 | $530.40M 10-Q · filed 2024-07-31 | $770.60M derived: sum of 3 quarters · filed 2026-02-25 | $1.01B derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $256.70M 10-Q · filed 2025-05-06 | $285.20M 10-Q · filed 2024-04-29 | $498.80M derived: sum of 2 quarters · filed 2026-02-25 | $741.60M derived: sum of 3 quarters · filed 2026-02-25 | $985.30M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $242.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $484.90M derived: sum of 2 quarters · filed 2026-02-25 | $728.60M derived: sum of 3 quarters · filed 2026-02-25 | $962.90M 10-K · filed 2026-02-25 | $1.07B 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $242.80M 10-Q · filed 2024-11-06 | $270.30M 10-Q · filed 2023-10-27 | $486.50M derived: sum of 2 quarters · filed 2024-11-06 | $720.80M 10-Q · filed 2024-11-06 | $801.80M 10-Q · filed 2023-10-27 | $878.30M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $243.70M 10-Q · filed 2024-07-31 | $270.30M 10-Q · filed 2023-07-28 | $478.50M 10-Q · filed 2024-07-31 | $531.50M 10-Q · filed 2023-07-28 | $635.50M derived: sum of 3 quarters · filed 2025-02-28 | $869.10M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $261.20M 10-Q · filed 2024-04-29 | $391.80M derived: sum of 2 quarters · filed 2025-02-28 | $625.40M derived: sum of 3 quarters · filed 2025-02-28 | $876.20M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $130.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $364.20M derived: sum of 2 quarters · filed 2025-02-28 | $615.00M derived: sum of 3 quarters · filed 2025-02-28 | $843.60M 10-K · filed 2025-02-28 | $945.20M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $233.60M 10-Q · filed 2023-10-27 | $484.40M derived: sum of 2 quarters · filed 2023-10-27 | $713.00M 10-Q · filed 2023-10-27 | $945.80M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $250.80M 10-Q · filed 2023-07-28 | $479.40M 10-Q · filed 2023-07-28 | $712.20M derived: sum of 3 quarters · filed 2024-02-12 | $950.20M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $228.60M 10-Q · filed 2023-04-28 | $461.40M derived: sum of 2 quarters · filed 2024-02-12 | $699.40M derived: sum of 3 quarters · filed 2024-02-12 | $924.70M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $232.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $470.80M derived: sum of 2 quarters · filed 2024-02-12 | $696.10M derived: sum of 3 quarters · filed 2024-02-12 | $903.10M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $238.00M 10-Q · filed 2022-10-28 | $463.30M derived: sum of 2 quarters · filed 2022-10-28 | $670.30M 10-Q · filed 2022-10-28 | $866.00M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $225.30M 10-Q · filed 2022-07-29 | $432.30M 10-Q · filed 2022-07-29 | $628.00M derived: sum of 3 quarters · filed 2023-02-13 | $823.50M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $207.00M 10-Q · filed 2022-04-28 | $402.70M derived: sum of 2 quarters · filed 2023-02-13 | $598.20M derived: sum of 3 quarters · filed 2023-02-13 | $780.30M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $195.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $391.20M derived: sum of 2 quarters · filed 2023-02-13 | $573.30M derived: sum of 3 quarters · filed 2023-02-13 | $760.70M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $195.50M 10-Q · filed 2021-10-29 | $377.60M derived: sum of 2 quarters · filed 2021-10-29 | $565.00M 10-Q · filed 2021-10-29 | $758.90M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $182.10M 10-Q · filed 2021-07-30 | $369.50M 10-Q · filed 2021-07-30 | $563.40M derived: sum of 3 quarters · filed 2022-02-14 | $758.90M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $187.40M 10-Q · filed 2021-04-28 | $381.30M derived: sum of 2 quarters · filed 2022-02-14 | $576.80M derived: sum of 3 quarters · filed 2022-02-14 | $768.70M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $193.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $389.40M derived: sum of 2 quarters · filed 2022-02-14 | $581.30M derived: sum of 3 quarters · filed 2022-02-14 | $752.70M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $195.50M 10-Q · filed 2020-10-26 | $387.40M derived: sum of 2 quarters · filed 2020-10-26 | $558.80M 10-Q · filed 2020-10-26 | $721.90M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $191.90M 10-Q · filed 2020-07-27 | $363.30M 10-Q · filed 2020-07-27 | $526.40M derived: sum of 3 quarters · filed 2021-02-12 | $688.20M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $171.40M 10-Q · filed 2020-04-28 | $334.50M derived: sum of 2 quarters · filed 2021-02-12 | $496.30M derived: sum of 3 quarters · filed 2021-02-12 | $650.40M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $163.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $324.90M derived: sum of 2 quarters · filed 2021-02-12 | $479.00M derived: sum of 3 quarters · filed 2021-02-12 | $622.20M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $161.80M 10-Q · filed 2019-10-25 | $315.90M derived: sum of 2 quarters · filed 2019-10-25 | $459.10M 10-Q · filed 2019-10-25 | $605.70M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $154.10M 10-Q · filed 2019-07-26 | $297.30M 10-Q · filed 2019-07-26 | $443.90M derived: sum of 3 quarters · filed 2020-02-14 | $586.80M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $143.20M 10-Q · filed 2019-04-26 | $289.80M derived: sum of 2 quarters · filed 2020-02-14 | $432.70M derived: sum of 3 quarters · filed 2020-02-14 | $567.10M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | $146.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $289.50M derived: sum of 2 quarters · filed 2020-02-14 | $423.90M derived: sum of 3 quarters · filed 2020-02-14 | $552.60M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $142.90M 10-Q · filed 2018-10-26 | $277.30M derived: sum of 2 quarters · filed 2018-10-26 | $406.00M 10-Q · filed 2018-10-26 | $520.90M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | $134.40M 10-Q · filed 2018-07-27 | $263.10M 10-Q · filed 2018-07-27 | $378.00M derived: sum of 3 quarters · filed 2019-02-15 | $491.00M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | $128.70M 10-Q · filed 2018-04-27 | $243.60M derived: sum of 2 quarters · filed 2019-02-15 | $356.60M derived: sum of 3 quarters · filed 2019-02-15 | $469.10M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | $114.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $227.90M derived: sum of 2 quarters · filed 2019-02-15 | $340.40M derived: sum of 3 quarters · filed 2019-02-15 | $442.20M 10-K · filed 2019-02-15 | $443.30M 10-K · filed 2017-02-17 | |||
| 2016-09-30 | $113.00M 10-Q · filed 2017-10-27 | $113.10M 10-Q · filed 2016-10-28 | $225.50M derived: sum of 2 quarters · filed 2017-10-27 | $327.30M 10-Q · filed 2017-10-27 | $328.40M 10-Q · filed 2016-10-28 | $425.30M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $112.50M 10-Q · filed 2017-07-28 | $112.90M 10-Q · filed 2016-07-29 | $214.30M 10-Q · filed 2017-07-28 | $215.30M 10-Q · filed 2016-07-29 | $312.30M derived: sum of 3 quarters · filed 2018-02-16 | $413.30M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $101.80M 10-Q · filed 2017-04-28 | $102.40M 10-Q · filed 2016-04-29 | $199.80M derived: sum of 2 quarters · filed 2018-02-16 | $300.80M derived: sum of 3 quarters · filed 2018-02-16 | $398.30M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $199.00M derived: sum of 2 quarters · filed 2018-02-16 | $296.50M derived: sum of 3 quarters · filed 2018-02-16 | $382.90M 10-K · filed 2018-02-16 | $383.10M 10-K · filed 2016-02-19 | |||
| 2015-09-30 | $101.00M 10-Q · filed 2016-10-28 | $198.50M derived: sum of 2 quarters · filed 2016-10-28 | $284.90M 10-Q · filed 2016-10-28 | $368.90M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $97.50M 10-Q · filed 2016-07-29 | $183.90M 10-Q · filed 2016-07-29 | $267.90M derived: sum of 3 quarters · filed 2017-02-17 | $355.50M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $86.40M 10-Q · filed 2016-04-29 | $170.40M derived: sum of 2 quarters · filed 2017-02-17 | $258.00M derived: sum of 3 quarters · filed 2017-02-17 | $347.10M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $171.60M derived: sum of 2 quarters · filed 2017-02-17 | $260.70M derived: sum of 3 quarters · filed 2017-02-17 | $346.50M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $87.60M 10-Q · filed 2015-10-29 | $176.70M derived: sum of 2 quarters · filed 2015-10-29 | $262.50M 10-Q · filed 2015-10-29 | $341.10M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $89.10M 10-Q · filed 2015-07-29 | $174.90M 10-Q · filed 2015-07-29 | $253.50M derived: sum of 3 quarters · filed 2016-02-19 | $337.60M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $85.80M 10-Q · filed 2015-04-29 | $164.40M derived: sum of 2 quarters · filed 2016-02-19 | $248.50M derived: sum of 3 quarters · filed 2016-02-19 | $329.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $78.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $162.70M derived: sum of 2 quarters · filed 2016-02-19 | $243.20M derived: sum of 3 quarters · filed 2016-02-19 | $323.00M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $84.10M 10-Q · filed 2014-10-31 | $164.60M derived: sum of 2 quarters · filed 2014-10-31 | $244.40M 10-Q · filed 2014-10-31 | $319.30M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $80.50M 10-Q · filed 2014-08-04 | $160.30M 10-Q · filed 2014-08-04 | $235.20M derived: sum of 3 quarters · filed 2015-02-20 | $309.00M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-03-31 | $79.80M 10-Q · filed 2014-05-02 | $154.70M derived: sum of 2 quarters · filed 2015-02-20 | $228.50M derived: sum of 3 quarters · filed 2015-02-20 | $302.50M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2012-12-31 | $74.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $148.70M derived: sum of 2 quarters · filed 2015-02-20 | $222.70M derived: sum of 3 quarters · filed 2015-02-20 | $291.30M 10-K · filed 2015-02-20 | ||||
| 2012-09-30 | $73.80M 10-Q · filed 2013-11-07 | $147.80M derived: sum of 2 quarters · filed 2013-11-07 | $216.40M 10-Q · filed 2013-11-07 | $277.10M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $74.00M 10-Q · filed 2013-08-06 | $142.60M 10-Q · filed 2013-08-06 | $203.30M derived: sum of 3 quarters · filed 2014-02-28 | $265.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $68.60M 10-Q · filed 2013-05-06 | $129.30M derived: sum of 2 quarters · filed 2014-02-28 | $191.00M derived: sum of 3 quarters · filed 2014-02-28 | $255.90M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $60.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $122.40M derived: sum of 2 quarters · filed 2014-02-28 | $187.30M derived: sum of 3 quarters · filed 2014-02-28 | $246.30M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $61.70M 10-Q · filed 2012-11-07 | $126.60M derived: sum of 2 quarters · filed 2012-11-07 | $185.60M 10-Q · filed 2012-11-07 | $241.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $64.90M 10-Q · filed 2012-08-07 | $123.90M 10-Q · filed 2012-08-07 | $179.80M derived: sum of 3 quarters · filed 2013-02-28 | $232.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $59.00M 10-Q · filed 2012-05-09 | $114.90M derived: sum of 2 quarters · filed 2013-02-28 | $167.60M derived: sum of 3 quarters · filed 2013-02-28 | $218.20M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $55.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $108.60M derived: sum of 2 quarters · filed 2013-02-28 | $159.20M derived: sum of 3 quarters · filed 2013-02-28 | $204.40M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $52.70M 10-Q · filed 2011-11-08 | $103.30M derived: sum of 2 quarters · filed 2011-11-08 | $148.50M 10-Q · filed 2011-11-08 | $196.80M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $50.60M 10-Q · filed 2011-08-08 | $95.80M 10-Q · filed 2011-08-08 | $144.10M derived: sum of 3 quarters · filed 2012-02-27 | $188.80M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $45.20M 10-Q · filed 2011-05-09 | $93.50M derived: sum of 2 quarters · filed 2012-02-27 | $138.20M derived: sum of 3 quarters · filed 2012-02-27 | $180.80M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $48.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $93.00M derived: sum of 2 quarters · filed 2012-02-27 | $135.60M derived: sum of 3 quarters · filed 2012-02-27 | $175.50M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $44.70M 10-Q · filed 2010-11-08 | $87.30M derived: sum of 2 quarters · filed 2010-11-08 | $127.20M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $42.60M 10-Q · filed 2010-08-06 | $82.50M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $139.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |